Manipulating the Intersection of Angiogenesis and Inflammation

Annals of Biomedical Engineering

Volumn 43, Issue 3, 2015, Pages 628-640

  Kwee, Brian J ^a,b   Mooney, David J ^a,b  

^a HARVARD UNIVERSITY   (United States)

^b HARVARD UNIVERSITY   (United States)

Author keywords

Biomaterials; Immune cells; Vascularization

Indexed keywords

BIOLOGICAL MATERIALS; BIOMATERIALS; IMMUNE SYSTEM; TISSUE ENGINEERING;

ANGIOGENIC FACTOR; FAVORABLE INTERACTIONS; IMMUNE CELLS; NEO-VASCULARIZATION; REGENERATIVE MEDICINE; VASCULAR CELLS; VASCULARIZATION; VESSEL FORMATION;

BLOOD VESSELS;

BIOMATERIAL;

ANGIOGENESIS; ANIMAL; HUMAN; IMMUNOLOGY; INFLAMMATION; TISSUE ENGINEERING;

ANIMALS; BIOCOMPATIBLE MATERIALS; HUMANS; INFLAMMATION; NEOVASCULARIZATION, PHYSIOLOGIC; TISSUE ENGINEERING;

EID: 84939937045     PISSN: 00906964     EISSN: 15739686     Source Type: Journal    
DOI: 10.1007/s10439-014-1145-y     Document Type: Article

References (99)

1. Ali, O. A., N. Huebsch, L. Cao, G. Dranoff, and D. J. Mooney. Infection-mimicking materials to program dendritic cells in situ. Nat. Mater. 8:151–158, 2009.
2. Alsberg, E., H. J. Kong, Y. Hirano, M. K. Smith, A. Albeiruti, and D. J. Mooney. Regulating bone formation via controlled scaffold degradation. J. Dent. Res. 82:903–908, 2003.
3. Anderson, J. M., A. Rodriguez, and D. T. Chang. Foreign body reaction to biomaterials. Semin. Immunol. 20:86–100, 2008.
4. Awojoodu, A. O., M. E. Ogle, L. S. Sefcik, D. T. Bowers, K. Martin, K. L. Brayman, K. R. Lynch, S. M. Peirce-Cottler, and E. Botchwey. Sphingosine 1-phosphate receptor 3 regulates recruitment of anti-inflammatory monocytes to microvessels during implant arteriogenesis. Proc. Natl. Acad. Sci. USA 110:13785–13790, 2013.
5. Ballotta, V., A. Driessen-Mol, C. V. Bouten, and F. P. Baaijens. Strain-dependent modulation of macrophage polarization within scaffolds. Biomaterials 35:4919–4928, 2014.
6. Barth, K. A., J. D. Waterfield, and D. M. Brunette. The effect of surface roughness on raw 264.7 macrophage phenotype. J. Biomed. Mater. Res. A 101:2679–2688, 2013.
7. Benitez-Bribiesca, L., A. Wong, D. Utrera, and E. Castellanos. The role of mast cell tryptase in neoangiogenesis of premalignant and malignant lesions of the uterine cervix. J. Histochem. Cytochem. 49:1061–1062, 2001.
8. Bhrany, A. D., C. A. Irvin, K. Fujitani, Z. Liu, and B. D. Ratner. Evaluation of a sphere-templated polymeric scaffold as a subcutaneous implant. JAMA Facial Plast. Surg. 15:29–33, 2013.
9. Blair, R. J., H. Meng, M. J. Marchese, S. Ren, L. B. Schwartz, M. G. Tonnesen, and B. L. Gruber. Human mast cells stimulate vascular tube formation. Tryptase is a novel, potent angiogenic factor. J. Clin. Investig. 99:2691–2700, 1997.
10. Blotnick, S., G. E. Peoples, M. R. Freeman, T. J. Eberlein, and M. Klagsbrun. T lymphocytes synthesize and export heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor, mitogens for vascular cells and fibroblasts: differential production and release by CD4+ and CD8+ T cells. Proc. Natl. Acad. Sci. USA 91:2890–2894, 1994.
11. Bota, P. C., A. M. Collie, P. Puolakkainen, R. B. Vernon, E. H. Sage, B. D. Ratner, and P. S. Stayton. Biomaterial topography alters healing in vivo and monocyte/macrophage activation in vitro. J. Biomed. Mater. Res. A 95:649–657, 2010.
12. Chan, G., and D. J. Mooney. Ca(2 +) released from calcium alginate gels can promote inflammatory responses in vitro and in vivo. Acta Biomater. 9:9281–9291, 2013.
13. Chehroudi, B., S. Ghrebi, H. Murakami, J. D. Waterfield, G. Owen, and D. M. Brunette. Bone formation on rough, but not polished, subcutaneously implanted ti surfaces is preceded by macrophage accumulation. J. Biomed. Mater. Res. A 93:724–737, 2010.
14. Chen, W., W. Jin, N. Hardegen, K. J. Lei, L. Li, N. Marinos, G. McGrady, and S. M. Wahl. Conversion of peripheral CD4+ CD25− naive t cells to CD4+ CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med. 198:1875–1886, 2003.
15. Chen, S., J. A. Jones, Y. Xu, H. Y. Low, J. M. Anderson, and K. W. Leong. Characterization of topographical effects on macrophage behavior in a foreign body response model. Biomaterials 31:3479–3491, 2010.
16. Conejo-Garcia, J. R., F. Benencia, M. C. Courreges, E. Kang, A. Mohamed-Hadley, R. J. Buckanovich, D. O. Holtz, A. Jenkins, H. Na, L. Zhang, D. S. Wagner, D. Katsaros, R. Caroll, and G. Coukos. Tumor-infiltrating dendritic cell precursors recruited by a beta-defensin contribute to vasculogenesis under the influence of Vegf-A. Nat. Med. 10:950–958, 2004.
17. Couffinhal, T., M. Silver, M. Kearney, A. Sullivan, B. Witzenbichler, M. Magner, B. Annex, K. Peters, and J. M. Isner. Impaired collateral vessel development associated with reduced expression of vascular endothelial growth factor in apoe−/− mice. Circulation 99:3188–3198, 1999.
18. Coussens, L. M., and Z. Werb. Inflammation and cancer. Nature 420:860–867, 2002.
19. Curiel, T. J., P. Cheng, P. Mottram, X. Alvarez, L. Moons, M. Evdemon-Hogan, S. Wei, L. Zou, I. Kryczek, G. Hoyle, A. Lackner, P. Carmeliet, and W. Zou. Dendritic cell subsets differentially regulate angiogenesis in human ovarian cancer. Cancer Res. 64:5535–5538, 2004.
20. DiPietro, L. A. Wound healing: the role of the macrophage and other immune cells. Shock 4:233–240, 1995.
21. Discher, D. E., P. Janmey, and Y. L. Wang. Tissue cells feel and respond to the stiffness of their substrate. Science 310:1139–1143, 2005.
22. Druecke, D., S. Langer, E. Lamme, J. Pieper, M. Ugarkovic, H. U. Steinau, and H. H. Homann. Neovascularization of poly(ether ester) block-copolymer scaffolds in vivo: long-term investigations using intravital fluorescent microscopy. J. Biomed. Mater. Res. A 68:10–18, 2004.
23. Drury, J. L., and D. J. Mooney. Hydrogels for tissue engineering: scaffold design variables and applications. Biomaterials 24:4337–4351, 2003.
24. Fantin, A., J. M. Vieira, G. Gestri, L. Denti, Q. Schwarz, S. Prykhozhij, F. Peri, S. W. Wilson, and C. Ruhrberg. Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of Vegf-mediated endothelial tip cell induction. Blood 116:829–840, 2010.
25. Franz, S., S. Rammelt, D. Scharnweber, and J. C. Simon. Immune responses to implants—a review of the implications for the design of immunomodulatory biomaterials. Biomaterials 32:6692–6709, 2011.
26. Freeman, M. R., F. X. Schneck, M. L. Gagnon, C. Corless, S. Soker, K. Niknejad, G. E. Peoples, and M. Klagsbrun. Peripheral blood t lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: a potential role for t cells in angiogenesis. Cancer Res. 55:4140–4145, 1995.
27. Galli, S. J., N. Borregaard, and T. A. Wynn. Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils. Nat. Immunol. 12:1035–1044, 2011.
28. Gruber, B. L., M. J. Marchese, K. Suzuki, L. B. Schwartz, Y. Okada, H. Nagase, and N. S. Ramamurthy. Synovial procollagenase activation by human mast cell tryptase dependence upon matrix metalloproteinase 3 activation. J. Clin. Investig. 84:1657–1662, 1989.
29. Hao, Q., Y. Chen, Y. Zhu, Y. Fan, D. Palmer, H. Su, W. L. Young, and G. Y. Yang. Neutrophil depletion decreases Vegf-induced focal angiogenesis in the mature mouse brain. J. Cereb. Blood Flow Metab. 27:1853–1860, 2007.
30. Harel-Adar, T., T. Ben Mordechai, Y. Amsalem, M. S. Feinberg, J. Leor, and S. Cohen. Modulation of cardiac macrophages by phosphatidylserine-presenting liposomes improves infarct repair. Proc. Natl. Acad. Sci. USA 108:1827–1832, 2011.
31. Heil, M., T. Ziegelhoeffer, F. Pipp, S. Kostin, S. Martin, M. Clauss, and W. Schaper. Blood monocyte concentration is critical for enhancement of collateral artery growth. Am. J. Physiol. Heart Circ. Physiol. 283:H2411–H2419, 2002.
32. Heil, M., T. Ziegelhoeffer, S. Wagner, B. Fernandez, A. Helisch, S. Martin, S. Tribulova, W. A. Kuziel, G. Bachmann, and W. Schaper. Collateral artery growth (arteriogenesis) after experimental arterial occlusion is impaired in mice lacking CC-chemokine receptor-2. Circ. Res. 94:671–677, 2004.
33. Heissig, B., S. Rafii, H. Akiyama, Y. Ohki, Y. Sato, T. Rafael, Z. Zhu, D. J. Hicklin, K. Okumura, H. Ogawa, Z. Werb, and K. Hattori. Low-dose irradiation promotes tissue revascularization through Vegf release from mast cells and mmp-9-mediated progenitor cell mobilization. J. Exp. Med. 202:739–750, 2005.
34. Hellingman, A. A., J. J. Zwaginga, R. T. van Beem, R. M. S. M. C. Te, J. F. Hamming, W. E. Fibbe, P. H. Quax, and S. B. Geutskens. T-cell-pre-stimulated monocytes promote neovascularisation in a murine hind limb ischaemia model. Eur. J. Vasc. Endovasc. Surg. 41:418–428, 2011.
35. Hetrick, E. M., H. L. Prichard, B. Klitzman, and M. H. Schoenfisch. Reduced foreign body response at nitric oxide-releasing subcutaneous implants. Biomaterials 28:4571–4580, 2007.
36. Hirosue, S., I. C. Kourtis, A. J. van der Vlies, J. A. Hubbell, and M. A. Swartz. Antigen delivery to dendritic cells by poly(propylene sulfide) nanoparticles with disulfide conjugated peptides: cross-presentation and t cell activation. Vaccine 28:7897–7906, 2010.
37. Huebsch, N., P. R. Arany, A. S. Mao, D. Shvartsman, O. A. Ali, S. A. Bencherif, J. Rivera-Feliciano, and D. J. Mooney. Harnessing traction-mediated manipulation of the cell/matrix interface to control stem-cell fate. Nat. Mater. 9:518–526, 2010.
38. Hunt, T. K., D. R. Knighton, K. K. Thakral, W. H. Goodson, 3rd, and W. S. Andrews. Studies on inflammation and wound healing: angiogenesis and collagen synthesis stimulated in vivo by resident and activated wound macrophages. Surgery 96:48–54, 1984.
39. Jin, R., G. Yang, and G. Li. Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J. Leukoc. Biol. 87:779–789, 2010.
40. Jones, J. A., D. T. Chang, H. Meyerson, E. Colton, I. K. Kwon, T. Matsuda, and J. M. Anderson. Proteomic analysis and quantification of cytokines and chemokines from biomaterial surface-adherent macrophages and foreign body giant cells. J. Biomed. Mater. Res. A 83:585–596, 2007.
41. Kao, W. J., and D. Lee. In vivo modulation of host response and macrophage behavior by polymer networks grafted with fibronectin-derived biomimetic oligopeptides: the role of RGD and PHSRN domains. Biomaterials 22:2901–2909, 2001.
42. Kao, W. J., D. Lee, J. C. Schense, and J. A. Hubbell. Fibronectin modulates macrophage adhesion and FBGC formation: the role of RGD, PHSRN, and PRRARV domains. J. Biomed. Mater. Res. 55:79–88, 2001.
43. Kearney, C. J., and D. J. Mooney. Macroscale delivery systems for molecular and cellular payloads. Nat. Mater. 12:1004–1017, 2013.
44. Khmelewski, E., A. Becker, T. Meinertz, and W. D. Ito. Tissue resident cells play a dominant role in arteriogenesis and concomitant macrophage accumulation. Circ. Res. 95:E56–E64, 2004.
45. Kim, J., W. A. Li, W. Sands, and D. J. Mooney. Effect of pore structure of macroporous poly(lactide-co-glycolide) scaffolds on the in vivo enrichment of dendritic cells. ACS Appl. Mater. Interfaces 6:8505–8512, 2014.
46. Koffler, J., K. Kaufman-Francis, Y. Shandalov, D. Egozi, D. A. Pavlov, A. Landesberg, and S. Levenberg. Improved vascular organization enhances functional integration of engineered skeletal muscle grafts. Proc. Natl. Acad. Sci. USA 108:14789–14794, 2011.
47. la Sala, A., L. Pontecorvo, A. Agresta, G. Rosano, and E. Stabile. Regulation of collateral blood vessel development by the innate and adaptive immune system. Trends Mol. Med. 18:494–501, 2012.
48. Lee, K. Y., M. C. Peters, K. W. Anderson, and D. J. Mooney. Controlled growth factor release from synthetic extracellular matrices. Nature 408:998–1000, 2000.
49. Li, W. A., and D. J. Mooney. Materials based tumor immunotherapy vaccines. Curr. Opin. Immunol. 25:238–245, 2013.
50. Lin, E. Y., J. F. Li, L. Gnatovskiy, Y. Deng, L. Zhu, D. A. Grzesik, H. Qian, X. N. Xue, and J. W. Pollard. Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Cancer Res. 66:11238–11246, 2006.
51. Lutolf, M. P., G. P. Raeber, A. H. Zisch, N. Tirelli, and J. A. Hubbell. Cell-responsive synthetic hydrogels. Adv. Mater. 15:888–892, 2003.
52. Lutolf, M. P., F. E. Weber, H. G. Schmoekel, J. C. Schense, T. Kohler, R. Muller, and J. A. Hubbell. Repair of bone defects using synthetic mimetics of collagenous extracellular matrices. Nat. Biotechnol. 21:513–518, 2003.
53. Madden, L. R., D. J. Mortisen, E. M. Sussman, S. K. Dupras, J. A. Fugate, J. L. Cuy, K. D. Hauch, M. A. Laflamme, C. E. Murry, and B. D. Ratner. Proangiogenic scaffolds as functional templates for cardiac tissue engineering. Proc. Natl. Acad. Sci. USA 107:15211–15216, 2010.
54. Mann, B. K., R. H. Schmedlen, and J. L. West. Tethered-TGF-β increases extracellular matrix production of vascular smooth muscle cells. Biomaterials 22(5):439–444, 2001.
55. Mantovani, A., A. Sica, S. Sozzani, P. Allavena, A. Vecchi, and M. Locati. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25:677–686, 2004.
56. Mantovani, A., S. Sozzani, M. Locati, P. Allavena, and A. Sica. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized m2 mononuclear phagocytes. Trends Immunol. 23:549–555, 2002.
57. McWhorter, F. Y., T. Wang, P. Nguyen, T. Chung, and W. F. Liu. Modulation of macrophage phenotype by cell shape. Proc. Natl. Acad. Sci. USA 110:17253–17258, 2013.
58. Mokarram, N., and R. V. Bellamkonda. A perspective on immunomodulation and tissue repair. Ann. Biomed. Eng. 42:338–351, 2014.
59. Mor, F., F. J. Quintana, and I. R. Cohen. Angiogenesis-inflammation cross-talk: vascular endothelial growth factor is secreted by activated T cells and induces Th1 polarization. J. Immunol. 172:4618–4623, 2004.
60. Mosser, D. M., and J. P. Edwards. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8:958–969, 2008.
61. Mountziaris, P. M., and A. G. Mikos. Modulation of the inflammatory response for enhanced bone tissue regeneration. Tissue. Eng. Part B 14:179–186, 2008.
62. Moyano, D. F., M. Goldsmith, D. J. Solfiell, D. Landesman-Milo, O. R. Miranda, D. Peer, and V. M. Rotello. Nanoparticle hydrophobicity dictates immune response. J. Am. Chem. Soc. 134:3965–3967, 2012.
63. Nikkhah, M., F. Edalat, S. Manoucheri, and A. Khademhosseini. Engineering microscale topographies to control the cell–substrate interface. Biomaterials 33:5230–5246, 2012.
64. Niklason, L. E., J. Gao, W. M. Abbott, K. K. Hirschi, S. Houser, R. Marini, and R. Langer. Functional arteries grown in vitro. Science 284:489–493, 1999.
65. Norrby, K. Mast cells and angiogenesis. APMIS 110:355–371, 2002.
66. Nozawa, H., C. Chiu, and D. Hanahan. Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Proc. Natl. Acad. Sci. USA 103:12493–12498, 2006.
67. Ohki, Y., B. Heissig, Y. Sato, H. Akiyama, Z. Zhu, D. J. Hicklin, K. Shimada, H. Ogawa, H. Daida, K. Hattori, and A. Ohsaka. Granulocyte colony-stimulating factor promotes neovascularization by releasing vascular endothelial growth factor from neutrophils. FASEB J. 19:2005–2007, 2005.
68. Park, J., S. H. Wrzesinski, E. Stern, M. Look, J. Criscione, R. Ragheb, S. M. Jay, S. L. Demento, A. Agawu, P. Licona Limon, A. F. Ferrandino, D. Gonzalez, A. Habermann, R. A. Flavell, and T. M. Fahmy. Combination delivery of TGF-beta inhibitor and il-2 by nanoscale liposomal polymeric gels enhances tumour immunotherapy. Nat. Mater. 11:895–905, 2012.
69. Patil, S. D., F. Papadimitrakopoulos, and D. J. Burgess. Dexamethasone-loaded poly(lactic-co-glycolic) acid microspheres/poly(vinyl alcohol) hydrogel composite coatings for inflammation control. Diabetes Technol. Ther. 6:887–897, 2004.
70. Pinhal-Enfield, G., M. Ramanathan, G. Hasko, S. N. Vogel, A. L. Salzman, G. J. Boons, and S. J. Leibovich. An angiogenic switch in macrophages involving synergy between toll-like receptors 2, 4, 7, and 9 and adenosine a(2a) receptors. Am. J. Pathol. 163:711–721, 2003.
71. Puxeddu, I., A. Alian, A. M. Piliponsky, D. Ribatti, A. Panet, and F. Levi-Schaffer. Human peripheral blood eosinophils induce angiogenesis. Int. J. Biochem. Cell Biol. 37:628–636, 2005.
72. Ribatti, D., A. Vacca, A. Marzullo, B. Nico, R. Ria, L. Roncali, and F. Dammacco. Angiogenesis and mast cell density with tryptase activity increase simultaneously with pathological progression in b-cell non-hodgkin’s lymphomas. Int. J. Cancer 85:171–175, 2000.
73. Riboldi, E., T. Musso, E. Moroni, C. Urbinati, S. Bernasconi, M. Rusnati, L. Adorini, M. Presta, and S. Sozzani. Cutting edge: proangiogenic properties of alternatively activated dendritic cells. J. Immunol. 175:2788–2792, 2005.
74. Richardson, T. P., M. C. Peters, A. B. Ennett, and D. J. Mooney. Polymeric system for dual growth factor delivery. Nat. Biotechnol. 19:1029–1034, 2001.
75. Roh, J. D., R. Sawh-Martinez, M. P. Brennan, S. M. Jay, L. Devine, D. A. Rao, T. Yi, T. L. Mirensky, A. Nalbandian, B. Udelsman, N. Hibino, T. Shinoka, W. M. Saltzman, E. Snyder, T. R. Kyriakides, J. S. Pober, and C. K. Breuer. Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling. Proc. Natl. Acad. Sci. USA 107:4669–4674, 2010.
76. Rowley, J. A., G. Madlambayan, and D. J. Mooney. Alginate hydrogels as synthetic extracellular matrix materials. Biomaterials 20:45–53, 1999.
77. Rucker, M., M. W. Laschke, D. Junker, C. Carvalho, A. Schramm, R. Mulhaupt, N. C. Gellrich, and M. D. Menger. Angiogenic and inflammatory response to biodegradable scaffolds in dorsal skinfold chambers of mice. Biomaterials 27:5027–5038, 2006.
78. Seong, S. Y., and P. Matzinger. Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nat. Rev. Immunol. 4:469–478, 2004.
79. Silva, E. A., E. S. Kim, H. J. Kong, and D. J. Mooney. Material-based deployment enhances efficacy of endothelial progenitor cells. Proc. Natl. Acad. Sci. USA 105:14347–14352, 2008.
80. Silvestre, J. S., Z. Mallat, A. Tedgui, and B. I. Levy. Post-ischaemic neovascularization and inflammation. Cardiovasc. Res. 78:242–249, 2008.
81. Sozzani, S., M. Rusnati, E. Riboldi, S. Mitola, and M. Presta. Dendritic cell-endothelial cell cross-talk in angiogenesis. Trends Immunol. 28:385–392, 2007.
82. Spiller, K. L., R. R. Anfang, K. J. Spiller, J. Ng, K. R. Nakazawa, J. W. Daulton, and G. Vunjak-Novakovic. The role of macrophage phenotype in vascularization of tissue engineering scaffolds. Biomaterials 35:4477–4488, 2014.
83. Stabile, E., M. S. Burnett, C. Watkins, T. Kinnaird, A. Bachis, A. la Sala, J. M. Miller, M. Shou, S. E. Epstein, and S. Fuchs. Impaired arteriogenic response to acute hindlimb ischemia in CD4-knockout mice. Circulation 108:205–210, 2003.
84. Stabile, E., T. Kinnaird, A. la Sala, S. K. Hanson, C. Watkins, U. Campia, M. Shou, S. Zbinden, S. Fuchs, H. Kornfeld, S. E. Epstein, and M. S. Burnett. CD8+ T lymphocytes regulate the arteriogenic response to ischemia by infiltrating the site of collateral vessel development and recruiting CD4+ mononuclear cells through the expression of interleukin-16. Circulation 113:118–124, 2006.
85. Stack, M. S., and D. A. Johnson. Human mast cell tryptase activates single-chain urinary-type plasminogen activator (pro-urokinase). J. Biol. Chem. 269:9416–9419, 1994.
86. Sunderkotter, C., K. Steinbrink, M. Goebeler, R. Bhardwaj, and C. Sorg. Macrophages and angiogenesis. J. Leukoc. Biol. 55:410–422, 1994.
87. Sussman, E. M., M. C. Halpin, J. Muster, R. T. Moon, and B. D. Ratner. Porous implants modulate healing and induce shifts in local macrophage polarization in the foreign body reaction. Ann. Biomed. Eng. 42:1508–1516, 2014.
88. Takeda, Y., S. Costa, E. Delamarre, C. Roncal, R. Leite de Oliveira, M. L. Squadrito, V. Finisguerra, S. Deschoemaeker, F. Bruyere, M. Wenes, A. Hamm, J. Serneels, J. Magat, T. Bhattacharyya, A. Anisimov, B. F. Jordan, K. Alitalo, P. Maxwell, B. Gallez, Z. W. Zhuang, Y. Saito, M. Simons, M. De Palma, and M. Mazzone. Macrophage skewing by PHD2 haplodeficiency prevents ischaemia by inducing arteriogenesis. Nature 479:122–126, 2011.
89. Tang, L., T. A. Jennings, and J. W. Eaton. Mast cells mediate acute inflammatory responses to implanted biomaterials. Proc. Natl. Acad. Sci. USA 95:8841–8846, 1998.
90. Thomas, S. N., A. J. van der Vlies, C. P. O’Neil, S. T. Reddy, S. S. Yu, T. D. Giorgio, M. A. Swartz, and J. A. Hubbell. Engineering complement activation on polypropylene sulfide vaccine nanoparticles. Biomaterials 32:2194–2203, 2011.
91. Tidball, J. G. Inflammatory processes in muscle injury and repair. Am. J. Physiol. Regul. Integr. Comp. Physiol. 288:R345–R353, 2005.
92. van Beem, R. T., W. A. Noort, C. Voermans, M. Kleijer, A. ten Brinke, S. M. van Ham, C. E. van der Schoot, and J. J. Zwaginga. The presence of activated CD4(+) T cells is essential for the formation of colony-forming unit-endothelial cells by CD14(+) cells. J. Immunol. 180:5141–5148, 2008.
93. van Weel, V., R. E. Toes, L. Seghers, M. M. Deckers, M. R. de Vries, P. H. Eilers, J. Sipkens, A. Schepers, D. Eefting, V. W. van Hinsbergh, J. H. van Bockel, and P. H. Quax. Natural killer cells and CD4+ T-cells modulate collateral artery development. Arterioscler. Thromb. Vasc. Biol. 27:2310–2318, 2007.
94. Willenborg, S., T. Lucas, G. van Loo, J. A. Knipper, T. Krieg, I. Haase, B. Brachvogel, M. Hammerschmidt, A. Nagy, N. Ferrara, M. Pasparakis, and S. A. Eming. CCR2 recruits an inflammatory macrophage subpopulation critical for angiogenesis in tissue repair. Blood 120:613–625, 2012.
95. Yang, L., L. M. DeBusk, K. Fukuda, B. Fingleton, B. Green-Jarvis, Y. Shyr, L. M. Matrisian, D. P. Carbone, and P. C. Lin. Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis. Cancer Cell 6:409–421, 2004.
96. Yoshida, M., J. Mata, and J. E. Babensee. Effect of poly(lactic-co-glycolic acid) contact on maturation of murine bone marrow-derived dendritic cells. J. Biomed. Mater. Res. A 80:7–12, 2007.
97. Zdolsek, J., J. W. Eaton, and L. Tang. Histamine release and fibrinogen adsorption mediate acute inflammatory responses to biomaterial implants in humans. J. Transl. Med. 5:31, 2007.
98. Zhao, X., J. Kim, C. A. Cezar, N. Huebsch, K. Lee, K. Bouhadir, and D. J. Mooney. Active scaffolds for on-demand drug and cell delivery. Proc. Natl. Acad. Sci. USA 108:67–72, 2011.
99. Zhou, X., Y. C. Luo, W. J. Ji, L. Zhang, Y. Dong, L. Ge, R. Y. Lu, H. Y. Sun, Z. Z. Guo, G. H. Yang, T. M. Jiang, and Y. M. Li. Modulation of mononuclear phagocyte inflammatory response by liposome-encapsulated voltage gated sodium channel inhibitor ameliorates myocardial ischemia/reperfusion injury in rats. PLoS ONE 8:e74390, 2013.